NANOFACILE

Accelerate and de-risk nanomedicine therapies R&D for faster, more effective results.

Facing long, costly RNA therapy development?

Nanofacile’s advanced technology reduces preclinical time tenfold for faster, more effective results.

Our Vision

A world where everyone can be healthier. A world where you, your friends, and your loved ones can have the best next-generation treatments.

A vision at reach now thanks to RNA therapies and lipid-based nanoparticles.

WHAT DO WE DO?

Nanofacile develops state-of-the-art technology that enables formulation scientists, medicinal chemists, and researchers to reduce development time, helping patients to get next-generation therapies faster.

We created nanomedicine in a box.

We offer an advanced technology device that reduces preclinical development from weeks to days.

WhatsApp Image 2024-05-30 at 8.33.21 AM.jpeg

Easy-to-use and integrate. Compatible with existing workflows and downstream experiments.

Encapsulate more faster. Adaptable throughput encapsulates different formulations at the same time in just minutes.

It can be used
in any wet lab.

Where are we?

Groundbreaking Start

Proof of Concept Achieved.

MVP Development & Alpha Testing

Beta Testing & Scale-Up

Ensuring Real-World Efficacy

Market Launch

Introducing Nanomedicine in a Box

Recipe Optimization

Precision in Lipid-Based Therapies

Our Story

The journey of Nanofacile started in 2016 with a Ph.D. student arriving in Canada, inspired by a vision to harness the latest advancements in engineering, biology, and nanomedicine to develop life-saving therapies more rapidly. However, from the outset, multiple obstacles were encountered as developing these therapies proved to be slow, costly, and heavily reliant on specialized expertise.

With close to a decade of R&D experience and insights gained from discussions with over 100 researchers, CEOs, and CTOs, it became evident that these challenges were a collective struggle among researchers and innovators globally. This realization triggered the formation of a dedicated team on a journey to overcome these barriers. In August 2023, Nanofacile was founded with the mission to empower biotech innovators to unlock their full potential. Supported by individuals, and organizations from diverse backgrounds, our goal is to accelerate and de-risk nanomedicine R&D, making groundbreaking therapies more accessible to those who need them most.

Who we are

Nanofacile accelerates and de-risks next-generation therapy R&D by providing advanced, adaptable and efficient tools for encapsulating therapeutic substances into lipid-based nanoparticles, empowering biotech innovators in academia and the pharmaceutical industry.